Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product (Reagents, Assay, Instruments, Software), Method, Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End User and Region - Global Forecast to 2025

Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product (Reagents, Assay, Instruments, Software), Method, Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End User and Region - Global Forecast to 2025

“The global sepsis diagnostics market is projected to grow at a CAGR of 8.5% during the forecast period.”
The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety of sepsis diagnostic devices. The sepsis diagnostics industry is segmented on the technology, product, method, pathogen, test type, end user, and region.

“The blood culture segment accounted for the largest share of the sepsis diagnostics industry, by end-user, in 2019.”
Based on end-users, the sepsis diagnostics market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In 2019, blood culture accounted for the largest share of the market due to the increasing incidences of sepsis coupled with the growing adoption of blood culture techniques for the diagnosis of sepsis.

“The blood culture media segment accounted for the largest share of the sepsis diagnostics market, by product, in 2019.”
The market, by product, is segmented into blood culture media, assays & reagents, instruments, and software. In 2019, the blood culture media segment accounted for the largest share of the sepsis diagnostics industry due to the usage of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

“North America accounted for the largest share of the sepsis diagnostics market in 2019.”
North America accounted for the largest share of the global market in 2019, followed by Europe. This can primarily be attributed to the extensive availability of advanced sepsis diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for infectious diseases.

Breakdown of supply-side primary interviews:
By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
By Designation: C-level (10%), Director-level (14%), and Others (76%)
By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)

Some of the prominent players in the sepsis diagnostics market are bioMérieux (France), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), and CytoSorbents (US).

Research Coverage
This report studies the sepsis diagnostics market based on technology, product, method, pathogen, test type, end-user, and region. It studies significant factors (such as drivers and restraints) affecting the market growth. The report also analyzes opportunities and challenges in the market for stakeholders. It provides details of the competitive landscape for market leaders with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape users emerging segments of the sepsis diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY USED FOR THE STUDY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET ESTIMATION METHODOLOGY
      • REVENUE MAPPING-BASED MARKET ESTIMATION
      • PROCEDURE-BASED MARKET ESTIMATION
      • PRIMARY RESEARCH VALIDATION
    • DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RESEARCH LIMITATIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • SEPSIS DIAGNOSTICS: MARKET OVERVIEW
    • SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
    • GEOGRAPHIC ANALYSIS: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT AND REGION
    • APAC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY AND END USER
    • SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
    • GEOGRAPHIC SNAPSHOT OF THE SEPSIS DIAGNOSTICS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DINAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
    • BLOOD CULTURE
      • BLOOD CULTURE HOLDS THE LARGEST SHARE OF THE TECHNOLOGY MARKET
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
    • IMMUNOASSAYS
      • PRODUCT DEVELOPMENT EFFORTS BY MAJOR PLAYERS HAVE ENSURED DEMAND FOR IMMUNOASSAYS
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
    • MOLECULAR DIAGNOSTICS
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
      • POLYMERASE CHAIN REACTION
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table PCR MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
      • MICROARRAYS
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
      • PEPTIDE NUCLEIC ACID-FLUORESCENT IN SITU HYBRIDIZATION
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
      • SYNDROMIC PANEL-BASED TESTING
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
    • FLOW CYTOMETRY
      • LACK OF STANDARDIZED PROTOCOLS IS A KEY RESTRAINT IN THIS MARKET SEGMENT
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
    • MICROFLUIDICS
      • GROWING ADOPTION OF ADVANCED & RAPID TESTING WILL FAVOR MARKET GROWTH IN THIS SEGMENT
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY END USER, 2017 - 2025 (USD MILLION)
    • BIOMARKERS
      • DESPITE POTENTIAL, NO SINGLE IDEAL BIOMARKER HAS BEEN IDENTIFIED FOR SEPSIS DIAGNOSTICS
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017-2025 (USD MILLION)
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
    • BLOOD CULTURE MEDIA
      • BLOOD CULTURE MEDIA DOMINATE THE PRODUCTS MARKET
        • Table SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)
    • ASSAYS & REAGENTS
      • INCREASING AWARENESS HAS DRIVEN THE USE OF ASSAYS & REAGENTS
        • Table SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION, 2017-2025 (USD MILLION)
    • INSTRUMENTS
      • MARKET IS CHARACTERIZED BY A SHIFT FROM TRADITIONAL & MANUAL INSTRUMENTS TO AUTOMATED SYSTEMS
        • Table SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2017-2025 (USD MILLION)
    • SOFTWARE
      • RISING USE OF AUTOMATED INSTRUMENTS WILL ENSURE DEMAND FOR SOFTWARE
        • Table SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY METHOD
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
    • CONVENTIONAL DIAGNOSTICS
      • CONVENTIONAL DIAGNOSTICS HOLDS LARGEST MARKET SHARE
        • Table CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2017-2025 (USD MILLION)
    • AUTOMATED DIAGNOSTICS
      • AUTOMATED DIAGNOSTICS SEGMENT TO GROW AT THE HIGHEST CAGR
        • Table AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
    • BACTERIAL SEPSIS
      • Table BACTERIAL SEPSIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
      • Table BACTERIAL SEPSIS MARKET, BY REGION, 2019-2025 (USD MILLION)
      • GRAM-NEGATIVE BACTERIAL SEPSIS
        • Table CAUSES OF ADULT SEPSIS: GRAM-NEGATIVE BACTERIA
        • Table GRAM-NEGATIVE BACTERIAL SEPSIS MARKET, BY REGION, 2019-2025 (USD MILLION)
      • GRAM-POSITIVE BACTERIAL SEPSIS
        • Table CAUSES OF ADULT SEPSIS: GRAM-POSITIVE BACTERIA
        • Table GRAM-POSITIVE BACTERIAL SEPSIS MARKET, BY REGION, 2019-2025 (USD MILLION)
    • FUNGAL SEPSIS
      • FUNGEMIA IS THE SECOND-BIGGEST CAUSE OF BLOODSTREAM INFECTIONS
        • Table FUNGAL SEPSIS MARKET, BY REGION, 2019-2025 (USD MILLION)
    • OTHER PATHOGENS
      • Table OTHER PATHOGENS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
    • LABORATORY TESTS
      • LABORATORY TESTS ARE THE MOST COMMON AND PREFERRED MODE OF TESTING
        • Table LABORATORY SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION, 2017-2025 (USD MILLION)
    • POINT-OF-CARE TESTS
      • RAPIDITY AND CONVENIENCE HAVE DRIVEN DEMAND FOR POC TESTS
        • Table POINT-OF-CARE SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
    • HOSPITALS
      • HOSPITALS HOLD THE LARGEST SHARE OF THE SEPSIS DIAGNOSTICS MARKET
        • Table SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2017-2025 (USD MILLION)
    • PATHOLOGY & REFERENCE LABORATORIES
      • INDEPENDENT LABORATORIES OFFER AFFORDABILITY AS WELL AS THE BENEFITS OF BUNDLED SERVICES
        • Table SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2017-2025 (USD MILLION)
    • RESEARCH LABORATORIES & ACADEMIC INSTITUTES
      • GOVERNMENT SUPPORT AND RISING AWARENESS HAVE ENSURED DEMAND FOR MARKET PRODUCTS IN THIS SEGMENT
        • Table SEPSIS DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2017-2025 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY REGION, 2017-2025 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
      • US
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • CANADA
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
    • EUROPE
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
      • GERMANY
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • FRANCE
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • UK
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • ITALY
        • Table ITALY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • SPAIN
        • Table SPAIN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
      • Table ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
      • JAPAN
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • CHINA
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • INDIA
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
      • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • MEXICO
        • Table MEXICO: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • HIGH CONSUMPTION OF IMMUNE SYSTEM-SUPPRESSING MEDICATIONS IS DRIVING SEPSIS OCCURRENCE
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017-2025 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS, 2016-2020
      • PARTNERSHIPS AND COLLABORATIONS, 2016-2020
      • MERGERS AND ACQUISITIONS, 2016-2020
      • MARKET EXPANSION, 2016-2020
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
  • COMPANY PROFILES
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • T2 BIOSYSTEMS
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • LUMINEX
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BRUKER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ABBOTT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • IMMUNEXPRESS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • RESPONSE BIOMEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • AXIS-SHIELD DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • CYTOSORBENTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MITSUBISHI CHEMICAL EUROPE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • EKF DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • EMERGING PLAYERS
      • SEEGENE
      • GENMARK DIAGNOSTICS
      • BODITECH MED
      • ALPHA LABORATORIES
      • ALIFAX S.R.L.
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook